" class="no-js "lang="en-US"> Industry News Archives - Page 115 of 151 - Medtech Alert
Monday, October 13, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Insightful Science Acquires LabArchives to Expand its Electronic Lab Notebook and LIMS Solutions for Scientific Discovery

Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]

Sandata Announces Emmet O'Gara as New Chief Executive Officer

Sandata is pleased to announce the appointment of Emmet O’Gara as the organization’s next Chief Executive Officer. […]

Dynacure Announces Strategic Collaboration and Option Agreement with Nippon Shinyaku

Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives […]

Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands

Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]

Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics

Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]

CN Bio and iiCON Announce COVID-19 Research Collaboration

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]

Genoskin Appoints Dr Nicolas Gaudenzio as Chief Scientific Officer

Genoskin, a biotechnology company that provides transformative platforms and tools leveraging live ex vivo human skin to […]

Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, Executive Vice President and Chief Operating Officer

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab) a clinical-stage biotech company focused on the discovery and development […]

Amgen Begins Construction On New Biomanufacturing Plant In Central Ohio

Amgen (NASDAQ:AMGN) today announced the groundbreaking of its newest biomanufacturing plant, located in New Albany, Ohio. The […]

£3 Million More to Reduce Brain Injuries at Birth

NHS maternity staff will benefit from a further £3 million to improve the safety of […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more